Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s10072-020-04887-4 http://scihub22266oqcxt.onion/10.1007/s10072-020-04887-4 33185785!7664586!33185785     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33185785&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Neurol+Sci 2021 ; 42 (4): 1527-1530 Nephropedia Template TP {{tp|p=33185785|t=2021. Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization |pdf=|usr=}}{{33185785}} gab.com Text Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization JO: Neurol Sci http://www.kidney.de/pget.php?&tw=1&pmid=33185785 #FOAvip BACKGROUND: COVID-19 patients present with delirium during their hospitalization. AIMS: To assess the incidence of delirium in hospitalized COVID-19 patients and analyze the possible association with demographic, clinical, laboratory, and pharmacological factors. METHODS: COVID-19 patients were assessed for clinical signs of delirium and administered the assessment test for delirium and cognitive impairment (4AT) and the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) scales. RESULTS: Out of the 56 patients of our cohort, 14 (25.0%) experienced delirium. The use of low molecular weight heparin (LMWH) (enoxaparin 1 mg/kg/daily) was less frequent in patients with delirium (p = 0.004) and was accompanied by lower C reactive protein (CRP) levels (p = 0.006). DISCUSSION: The use of LMWH was associated with absence of delirium, independently of comorbidities and age. CONCLUSIONS: The use of LMWH may help preventing the occurrence of delirium in COVID-19 patients, with possible reduction of length of stay in the hospital and sequelae. Twit Text FOAVip Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization ????Neurol Sci http://www.kidney.de/pget.php?&tw=1&pmid=33185785 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33185785 #FOAvip English Wikipedia <ref>{{Cite pmid|33185785}}</ref> Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization #MMPMID33185785 D'Ardes D; Carrarini C; Russo M; Dono F; Speranza R; Digiovanni A; Martinotti G; Di Iorio A; Onofrj M; Cipollone F; Bonanni L Neurol Sci 2021[Apr]; 42 (4): 1527-1530 PMID33185785show ga BACKGROUND: COVID-19 patients present with delirium during their hospitalization. AIMS: To assess the incidence of delirium in hospitalized COVID-19 patients and analyze the possible association with demographic, clinical, laboratory, and pharmacological factors. METHODS: COVID-19 patients were assessed for clinical signs of delirium and administered the assessment test for delirium and cognitive impairment (4AT) and the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) scales. RESULTS: Out of the 56 patients of our cohort, 14 (25.0%) experienced delirium. The use of low molecular weight heparin (LMWH) (enoxaparin 1 mg/kg/daily) was less frequent in patients with delirium (p = 0.004) and was accompanied by lower C reactive protein (CRP) levels (p = 0.006). DISCUSSION: The use of LMWH was associated with absence of delirium, independently of comorbidities and age. CONCLUSIONS: The use of LMWH may help preventing the occurrence of delirium in COVID-19 patients, with possible reduction of length of stay in the hospital and sequelae. |Aged[MESH] |Aged, 80 and over[MESH] |Anticoagulants/*therapeutic use[MESH] |C-Reactive Protein/analysis[MESH] |COVID-19/*complications/psychology[MESH] |Cognition Disorders/etiology/psychology[MESH] |Cohort Studies[MESH] |Comorbidity[MESH] |Confusion/psychology[MESH] |Delirium/*etiology/*prevention & control/psychology[MESH] |Enoxaparin/*therapeutic use[MESH] |Female[MESH] |Heparin, Low-Molecular-Weight/*therapeutic use[MESH] |Humans[MESH] |Inpatients[MESH] |Length of Stay[MESH] |Male[MESH]Low molecular weight heparin in COVID-19 patients prevents delirium an(epmc).pdf DeepDyve Pubget Overpricing